Original language | English |
---|---|
Article number | dyq192 |
Pages (from-to) | 43-54 |
Number of pages | 12 |
Journal | International Journal of Epidemiology |
Volume | 41 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 1 2012 |
Externally published | Yes |
ASJC Scopus subject areas
- Epidemiology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: International Journal of Epidemiology, Vol. 41, No. 1, dyq192, 01.02.2012, p. 43-54.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Cohort profile
T2 - The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
AU - Hamers, Raph L.
AU - Oyomopito, Rebecca
AU - Kityo, Cissy
AU - Phanuphak, Praphan
AU - Siwale, Margaret
AU - Sungkanuparph, Somnuek
AU - Conradie, Francesca
AU - Kumarasamy, Nagalingeswaran
AU - Botes, Mariette E.
AU - Sirisanthana, Thira
AU - Abdallah, Saade
AU - Li, Patrick C.K.
AU - Ngorima, Nicoletta
AU - Kantipong, Pacharee
AU - Osibogun, Akin
AU - Lee, Christopher K.C.
AU - Stevens, Wendy S.
AU - Kamarulzaman, Adeeba
AU - Derdelinckx, Inge
AU - Chen, Yi Ming Arthur
AU - Schuurman, Rob
AU - Van vugt, Michèle
AU - Rinke de wit, Tobias F.
AU - Njovu, C.
AU - Labib, M.
AU - Menke, J.
AU - Sanne, I.
AU - Wallis, C. L.
AU - Hardman, M.
AU - Wellington, M.
AU - Luthy, R.
AU - Mandaliya, K.
AU - Jao, I.
AU - Dolan, M.
AU - Namayanja, G.
AU - Nakatudde, L.
AU - Kiconco, M.
AU - Abwola, M.
AU - Mugyenyi, P.
AU - Ndembiz, N.
AU - Kaleebu, P.
AU - Akanmu, S.
AU - Wensing, A. M.
AU - Sigaloff, K.
AU - Straatsma, E.
AU - Lee, M. P.
AU - Wong, K. H.
AU - Saghayam, S.
AU - Yang, Y. W.
AU - Han, S. H.
N1 - Funding Information: The PharmAccess African Studies to Evaluate Resistance is an initiative of PharmAccess Foundation, supported by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454). The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a programme of amfAR, The Foundation for AIDS Research, with major support provided by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454), and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in the study design, data collection, data analysis, data interpretation, decision to publish or writing of the report. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. Funding Information: Through the LAASER programme, PASER and TASER receive financial support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, PharmAccess Foundation, TREAT Asia (a programme of amfAR, The Foundation for AIDS research) and International Civil Society Support. PASER-M is coordinated by PharmAccess Foundation, in collaboration with the Amsterdam Institute for Global Health and Development (AIGHD) and the Virology Department at the University Medical Center Utrecht, The Netherlands. TASER-M is coordinated by TREAT Asia and its statistical and data management centre is the National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales in Sydney, Australia.
PY - 2012/2/1
Y1 - 2012/2/1
UR - http://www.scopus.com/inward/record.url?scp=84863383426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863383426&partnerID=8YFLogxK
U2 - 10.1093/ije/dyq192
DO - 10.1093/ije/dyq192
M3 - Article
C2 - 21071386
AN - SCOPUS:84863383426
SN - 0300-5771
VL - 41
SP - 43
EP - 54
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
IS - 1
M1 - dyq192
ER -